Immunotherapy options for leukemia patients
Presented as a part of our 2026 Spring WEBINAR Series.
Monday, April 27 I 7:00pm - 8:00pm CT (5:00pm PT, 6:00pm MT, 8:00pm ET)
There are now multiple treatment options for acute and chronic leukemia patients that are approved or in development in the category of “immunotherapy.”
What is immunotherapy? How is it different from chemotherapy and other available treatments? What side effects might a patient experience after receiving treatment and how are they addressed?
Get answers to these and other questions from our panel of experts. We hope you can join us!
Speakers
Gregory Behbehani, MD, PhD
The Ohio State University
Adam Kittai, MD
NYU Grossman Long Island School of Medicine
Spring series supporter
Sustaining supporter
Session supporter
